These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 33860983)

  • 1. Mass spectrometry-based proteomic platforms for better understanding of SARS-CoV-2 induced pathogenesis and potential diagnostic approaches.
    Ahsan N; Rao RSP; Wilson RS; Punyamurtula U; Salvato F; Petersen M; Ahmed MK; Abid MR; Verburgt JC; Kihara D; Yang Z; Fornelli L; Foster SB; Ramratnam B
    Proteomics; 2021 May; 21(10):e2000279. PubMed ID: 33860983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic Approaches to Study SARS-CoV-2 Biology and COVID-19 Pathology.
    Haas P; Muralidharan M; Krogan NJ; Kaake RM; Hüttenhain R
    J Proteome Res; 2021 Feb; 20(2):1133-1152. PubMed ID: 33464917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.
    Stukalov A; Girault V; Grass V; Karayel O; Bergant V; Urban C; Haas DA; Huang Y; Oubraham L; Wang A; Hamad MS; Piras A; Hansen FM; Tanzer MC; Paron I; Zinzula L; Engleitner T; Reinecke M; Lavacca TM; Ehmann R; Wölfel R; Jores J; Kuster B; Protzer U; Rad R; Ziebuhr J; Thiel V; Scaturro P; Mann M; Pichlmair A
    Nature; 2021 Jun; 594(7862):246-252. PubMed ID: 33845483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2/human interactome reveals ACE2 locus crosstalk with the immune regulatory network in the host.
    Lite C; Ahmed SSSJ; Juliet M; Freddy AJ
    Pathog Dis; 2021 Feb; 79(2):. PubMed ID: 33469663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open Science Resources for the Mass Spectrometry-Based Analysis of SARS-CoV-2.
    Bittremieux W; Adams C; Laukens K; Dorrestein PC; Bandeira N
    J Proteome Res; 2021 Mar; 20(3):1464-1475. PubMed ID: 33605735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteome-wide data analysis reveals tissue-specific network associated with SARS-CoV-2 infection.
    Feng L; Yin YY; Liu CH; Xu KR; Li QR; Wu JR; Zeng R
    J Mol Cell Biol; 2020 Jun; 12(12):946-957. PubMed ID: 32642770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
    Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
    Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome.
    Messina F; Giombini E; Montaldo C; Sharma AA; Zoccoli A; Sekaly RP; Locatelli F; Zumla A; Maeurer M; Capobianchi MR; Lauria FN; Ippolito G
    Cell Death Dis; 2021 Aug; 12(8):788. PubMed ID: 34385425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection.
    Messina F; Giombini E; Agrati C; Vairo F; Ascoli Bartoli T; Al Moghazi S; Piacentini M; Locatelli F; Kobinger G; Maeurer M; Zumla A; Capobianchi MR; Lauria FN; Ippolito G;
    J Transl Med; 2020 Jun; 18(1):233. PubMed ID: 32522207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-Based Insights Into the SARS-CoV-2-Mediated COVID-19 Pandemic: A Review of the First Year of Research.
    Praissman JL; Wells L
    Mol Cell Proteomics; 2021; 20():100103. PubMed ID: 34089862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
    Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
    Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
    Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Analysis of Respiratory Tissue and Cell Line Models to Examine Glycosylation Machinery during SARS-CoV-2 Infection.
    Oommen A; Cunningham S; Joshi L
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33435561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics-based mass spectrometry profiling of SARS-CoV-2 infection from human nasopharyngeal samples.
    Chatterjee S; Zaia J
    Mass Spectrom Rev; 2024; 43(1):193-229. PubMed ID: 36177493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples.
    Leng L; Cao R; Ma J; Mou D; Zhu Y; Li W; Lv L; Gao D; Zhang S; Gong F; Zhao L; Qiu B; Xiang H; Hu Z; Feng Y; Dai Y; Zhao J; Wu Z; Li H; Zhong W
    Signal Transduct Target Ther; 2020 Oct; 5(1):240. PubMed ID: 33060566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells.
    Han Q; Wang J; Luo H; Li L; Lu X; Liu A; Deng Y; Jiang Y
    Aging (Albany NY); 2021 Mar; 13(7):9160-9185. PubMed ID: 33744846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic landscape of SARS-CoV-2- and MERS-CoV-infected primary human renal epithelial cells.
    Kohli A; Sauerhering L; Fehling SK; Klann K; Geiger H; Becker S; Koch B; Baer PC; Strecker T; Münch C
    Life Sci Alliance; 2022 May; 5(5):. PubMed ID: 35110370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells.
    Appelberg S; Gupta S; Svensson Akusjärvi S; Ambikan AT; Mikaeloff F; Saccon E; Végvári Á; Benfeitas R; Sperk M; Ståhlberg M; Krishnan S; Singh K; Penninger JM; Mirazimi A; Neogi U
    Emerg Microbes Infect; 2020 Dec; 9(1):1748-1760. PubMed ID: 32691695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of targeted mass spectrometry in bottom-up proteomics for systems biology research.
    Manes NP; Nita-Lazar A
    J Proteomics; 2018 Oct; 189():75-90. PubMed ID: 29452276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.